Diroximel is a drug substance used in the treatment of neurological disorders such as multiple sclerosis. However, during the manufacturing process of diroximel, impurities may be formed which can affect the safety and efficacy of the drug. These impurities need to be carefully identified, quantified and controlled to ensure the quality and purity of the final product. This requires a thorough understanding of the chemistry involved in the manufacturing process, as well as the use of advanced analytical techniques to detect and quantify